Sanofi (SNYNF.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec17

Sanofi's Aficamten Receives Marketing Approval in China

13:16

Sanofi's Efdoralprin alfa Drug Receives Orphan Drug Designation in the EU

06:45

Sanofi's drug Efdoralprin Alfa receives FDA Fast Track and Orphan Drug designation

06:07

Dec15

Adel Signs a $1.04 Billion Global License Agreement with Sanofi for Adel-Y01

21:28

ADEL, Inc. enters into a $1.04 billion global licensing agreement with Sanofi for Alzheimer's therapy

21:20

Sanofi Announces Tolebrutinib Fails to Meet Expectations in Phase III Trials

13:28

Schedules & Filings

Schedules

Filings

Jan29

Earning Release(EST)

FY2025 Q4 Earning Release

Oct24

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15.45 B, Net Income 3.286 B, EPS 2.6976

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.57 B, Net Income 4.612 B, EPS 3.7893

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change